Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

GnRH treatment can reduce breast cancer cell invasion.

Thallium poisoning can be identified through radiological signs and treated effectively with B.A.L.

The document cannot be understood or processed.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Prenatal diagnosis of trichothiodystrophy is possible in the second trimester using fetal eyebrow biopsy, with sulfur content analysis being more reliable.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Light therapy can help heal soft tissue injuries and reduce pain and inflammation.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

The combination treatment showed a higher response rate but no significant survival benefits.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Congenital triangular alopecia is more common than thought and some treatments can be beneficial for appearance concerns.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Delayed PRP treatment may help ACL healing in older patients.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.